Author:
Kesler Shelli R.,Noll Kyle,Cahill Daniel P.,Rao Ganesh,Wefel Jeffrey S.
Funder
National Cancer Institute
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Reference72 articles.
1. Baldock AL, Yagle K, Born DE, Ahn S, Trister AD, Neal M, Johnston SK, Bridge CA, Basanta D, Scott J (2014) Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status. Neurooncol 16:779–786
2. Hodges TR, Choi BD, Bigner DD, Yan H, Sampson JH (2013) Isocitrate dehydrogenase 1 (IDH1): what it means to the neurosurgeon. J Neurosurg 118:1176
3. Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch T (2010) Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol 120:707–718
4. Cheng H-B, Yue W, Xie C, Zhang R-Y, Hu S-S, Wang Z (2013) IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis. Tumor Biol 34:3555–3559
5. Finger S (2013) Lesion momentum and behavior. In: Finger S (ed) Recovery from brain damage. Springer, New York, pp 135–164
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献